The Oncologist provides unique perspectives of important oncology meetings and symposia, highlighting significant advances in cancer research and cancer patient care.

2021 San Antonio Breast Cancer Symposium Highlights
  December 7–10, 2021
     Join The Oncologist’s Conference Perspective Series for ongoing updates from SABCS 2021, including an interview with Laura Spring, MD, a clinical investigator, and breast oncologist at Massachusetts General Hospital Cancer Center, on the key take-home lessons from San Antonio.

2021 ASCO Annual Meeting Highlights: Breast Cancer
  June 4–8, 2021
     Join The Oncologist’s Conference Perspectives Series for ongoing updates on the latest breast cancer research, including an interview with Virginia Kaklamani, MD, leader of the Breast Cancer Program at UT Health San Antonio MD Anderson Cancer Center, on the key take-home lessons from ASCO 2021.

2020 San Antonio Breast Cancer Symposium Highlights
  December 8–11, 2020
     The 2020 San Antonio Breast Cancer Symposium (SABCS) highlighted practice-changing research on optimal breast cancer treatment. A major theme included the growth of personalized therapy, with new data guiding treatment decisions within distinct patient subgroups. Join The Oncologist’s Conference Perspectives Series for coverage of the most promising breast cancer research presented.

2020 ASH Annual Meeting Highlights: Leukemia
  December 5–8, 2020
        The 62nd American Society of Hematology (ASH) Annual Meeting featured more than 450 abstracts on leukemia, with an emphasis on targeted therapy. Notably, half of the late-breaking abstracts focus on the molecular characterization and personalized treatment of leukemia. Join The Oncologist’s Conference Perspectives series for coverage of the most promising leukemia studies presented.

2020 ASCO Annual Meeting Highlights: Lymphoma
  May 29–31, 2020
       The 2020 American Society of Clinical Oncology (ASCO) Virtual Scientific Program, May 29–31, 2020, featured nearly 500 abstracts on lymphoma. Join The Oncologist’s Conference Perspectives series for coverage of the most promising lymphoma studies presented at ASCO 2020.

2018 ASH Annual Meeting Highlights
  December 1-4, 2018, San Diego, CA
       The 60th Annual Meeting of the American Society of Hematology (ASH) hosted more than 25,000 hematology professionals and featured practice-changing updates on hematologic malignancies. The Oncologist Conference Perspectives looks at the most promising research in leukemia and lymphoma.

2018 ASCO Annual Meeting Highlights: Colorectal Cancer
  June 1-5, 2018, Chicago, Illinois
       The 2018 Annual Meeting of the American Society of Clinical Oncology (ASCO), June 1-5, 2018, in Chicago, Illinois, featured more than 500 abstracts on colorectal cancer (CRC). Join The Oncologist's Conference Perspectives series for coverage of the most promising research in CRC.

2017 ASH Annual Meeting Highlights
  December 9-12, 2017, Atlanta, Georgia
       The 59th Annual Meeting of the American Society of Hematology (ASH) hosted more than 25,000 hematology professionals and featured practice-changing updates on hematologic malignancies. The Oncologist Conference Perspectives looks at the most promising research in leukemia and lymphoma.

Special Report from 2017 ESMO Annual Meeting
  September 8-12, 2017, Madrid, Spain
       At the European Society for Medical Oncology (ESMO) 2017 Congress, held September 8-12, 2017, in Madrid, Spain, the theme was "integrating science into oncology for a better patient outcome." In this ESMO 2017 Special Report, The Oncologist focuses on new research on the use of prognostic and predictive biomarkers in the individualized management of patients with colorectal cancer.

Highlights from 2016 ASH Annual Meeting
  December 3-6, 2016, San Diego, California
       The 58th Annual Meeting of the American Society of Hematology (ASH), December 3-6, 2016, in San Diego, California, will feature more than 600 abstracts on lymphoma. The Oncologist meeting coverage looks promising research across the spectrum of lymphoma subtypes.

Highlights from 2016 ASCO Annual Meeting
  June 3-7, 2016, Chicago, Illinois
       The 2016 Annual Meeting of the American Society of Clinical Oncology (ASCO) featured more than 580 abstracts on non-small cell lung cancer (NSCLC). The Oncologist spoke with Nathan Pennell, MD, PhD, Director of the Taussig Cancer Center Lung Cancer Medical Oncology Program and Associate Professor of Medical Oncology at the Cleveland Clinic in Cleveland, Ohio, about particularly notable abstracts in NSCLC research.

Highlights from 2015 ASH Annual Meeting
  December 5-8, 2015, Orlando, Florida
       The 57th Annual Meeting of the American Society of Hematology (ASH) featured key advances in lymphoma treatment. New findings from ongoing clinical trials provide guidance on the optimal use of approved therapy and offer a preview of next-generation therapies that will shape the future management of lymphoma.

Highlights from 2014 ASH Annual Meeting
  December 5-9, 2014, San Francisco, CA
       Multidisciplinary approaches to the prevention, screening, evaluation, and management of hematologic malignancies.

Highlights from 2013 ASCO Annual Meeting: covering significant advances in cancer research and cancer patient care.
  May 31-June 4, 2013, Chicago, Illinois
       Featured topics include: lung cancer, melanoma, clinical trials, and leukemia research

Highlights from 2013 ASCO GU
  February 14-16, 2013, Orlando, Florida